The investment seeks to provide shareholders with high total return through current income and, secondarily, through capital appreciation... Show more
Category EmergingMarketsBond
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BAHAX | 17.83 | 0.37 | +2.12% |
| Brown Advisory WMC Strat Eurp Eq Adv | |||
| FDVAX | 31.24 | 0.20 | +0.64% |
| Fidelity Advisor Diversified Intl A | |||
| LAFYX | 22.53 | 0.04 | +0.18% |
| Lord Abbett Affiliated I | |||
| SCCUX | 12.33 | N/A | N/A |
| Invesco Income Advantage U.S. Fund C | |||
| CCISX | 13.80 | -0.22 | -1.57% |
| Calamos International Small Cap Gr C | |||
A.I.dvisor indicates that over the last year, REBAX has been closely correlated with VGIVX. These tickers have moved in lockstep 97% of the time. This A.I.-generated data suggests there is a high statistical probability that if REBAX jumps, then VGIVX could also see price increases.
| Ticker / NAME | Correlation To REBAX | 1D Price Change % | ||
|---|---|---|---|---|
| REBAX | 100% | N/A | ||
| VGIVX - REBAX | 97% Closely correlated | +0.04% | ||
| VEMBX - REBAX | 96% Closely correlated | N/A | ||
| MEDFX - REBAX | 92% Closely correlated | +0.08% | ||
| MEDEX - REBAX | 91% Closely correlated | +0.08% | ||
| MEDIX - REBAX | 91% Closely correlated | +0.08% | ||
More | ||||